ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Automated Liquid Handling Protocol Developer at Cellares - ApplyBlast

Automated Liquid Handling Protocol Developer

Cellares

15 days ago

4.5 on Glassdoor

South San Francisco, California, United States

Onsite

Full Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

This role involves designing and developing automated liquid handling protocols to platform new assays onto the Cell Q system, partnering with Analytical Development to translate manual assays into automation-compatible methods. The position requires writing and maintaining Biosero Green Button Go code, conducting validation experiments, and troubleshooting automated methods to ensure functionality and performance. The successful candidate will collaborate with cross-functional teams to support the transition of developed assays into validated production use while maintaining detailed documentation.

Responsibilities

Design and develop automated liquid handling protocols for Cell Q system
Write and maintain Biosero Green Button Go code for automation solutions
Translate manually developed assays into automation-compatible methods

Skills

About Cellares

cellares.com

Headquarters

South San Francisco, California, United States

Company Size

51-200 employees

Founded

2019

View Profile

Cellares is the first Integrated Development and Manufacturing Organization (IDMO) that applies an Industry 4.0 approach to mass manufacture the “living drugs” of the 21st century. The company develops and operates integrated technologies and automated manufacturing systems for cell therapies to accelerate access to life‑saving treatments. By combining development, engineering, and scalable production, Cellares aims to simplify and industrialize cell therapy manufacturing. It positions itself as a platform-driven partner for bringing next‑generation cell therapies to patients more reliably and at scale.